Imatinib D4 is the octa-deuterated form of Imatinib (STI-571; Gleevec; Glivec), which is an orally bioavailable multi-kinase inhibitor of v-Abl, c-Kit and PDGFR approved for cancer treatment (e.g. leukemias).

纯度：≥98%

CAS：1092942-82-9